Mesoporous silica nanoparticles in drug delivery and biomedical applications

Nanomedicine: Nanotechnology, Biology, and Medicine

Volumn 11, Issue 2, 2015, Pages 313-327

  Wang, Ying ^a   Zhao, Qinfu ^a   Han, Ning ^a   Bai, Ling ^a   Li, Jia ^a   Liu, Jia ^a   Che, Erxi ^a   Hu, Liang ^a   Zhang, Qiang ^a   Jiang, Tongying ^a   Wang, Siling ^a  

^a SHENYANG PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

Biocompatibility; Biomedical applications; Drug delivery systems; Mesoporous silica nanoparticles

Indexed keywords

BIOCOMPATIBILITY; MEDICAL APPLICATIONS; MESOPOROUS MATERIALS; NANOPARTICLES; SILICA; SILICA NANOPARTICLES; TARGETED DRUG DELIVERY;

BIO-IMAGING; BIOACTIVE MATERIAL; BIOMEDICAL APPLICATIONS; DRUG DELIVERY SYSTEM; LARGE SURFACE AREA; MESOPOROUS SILICA NANOPARTICLES; PORE VOLUME;

CONTROLLED DRUG DELIVERY;

ANTISENSE OLIGONUCLEOTIDE; CHITOSAN; CILOSTAZOL; CONTRAST MEDIUM; CYTOCHROME C; FLUORESCEIN ISOTHIOCYANATE; FLUORESCENT DYE; GLUTATHIONE; LANTHANIDE; LIPOSOME; MESOPOROUS SILICA NANOPARTICLE; PACLITAXEL; PLASMID DNA; POLYMER; QUANTUM DOT; RHODAMINE B; SALVIANOLIC ACID B; SILICA NANOPARTICLE; SMALL INTERFERING RNA; TELMISARTAN; UNCLASSIFIED DRUG; BIOMATERIAL; NANOPARTICLE; SILICON DIOXIDE;

CACO 2 CELL LINE; CONFOCAL LASER MICROSCOPY; CONTROLLED DRUG RELEASE; COVALENT BOND; DISULFIDE BOND; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; DRUG DIFFUSION; DRUG PENETRATION; DRUG SOLUBILITY; DRUG STORAGE; FLUORESCENCE IMAGING; GASTROINTESTINAL ABSORPTION; GENETIC TRANSFECTION; HELA CELL LINE; HUMAN; HYDROPHOBICITY; IMMUNE RESPONSE; MORPHOLOGY; OXIDATION REDUCTION POTENTIAL; PARTICLE SIZE; PORE MORPHOLOGY; REVIEW; STATIC ELECTRICITY; SUSTAINED DRUG RELEASE; TISSUE REGENERATION; ZETA POTENTIAL; CHEMISTRY; POROSITY;

BIOCOMPATIBLE MATERIALS; DRUG DELIVERY SYSTEMS; HUMANS; NANOPARTICLES; POROSITY; SILICON DIOXIDE;

EID: 84922763040     PISSN: 15499634     EISSN: 15499642     Source Type: Journal    
DOI: 10.1016/j.nano.2014.09.014     Document Type: Review

References (103)

1. Lanone S., Boczkowski J. Biomedical applications and potential health risks of nanomaterials: molecular mechanisms. Curr Mol Med 2006, 6:651-663.
2. Mulder W.J., Strijkers G.J., Van Tilborg G.A., Cormode D.P., Fayad Z.A., Nicolay K. Nanoparticulate assemblies of amphiphiles and diagnostically active materials for multimodality imaging. Acc Chem Res 2009, 42:904-914.
3. Sahoo S.K., Labhasetwar V. Nanotech approaches to drug delivery and imaging. Drug Discov Today 2003, 8:1112-1120.
4. Farokhzad O.C., Langer R. Nanomedicine: developing smarter therapeutic and diagnostic modalities. Adv Drug Deliv Rev 2006, 58:1456-1459.
5. Caruthers S.D., Wickline S.A., Lanza G.M. Nanotechnological applications in medicine. Curr Opin Biotechnol 2007, 18:26-30.
6. Shi J., Votruba A.R., Farokhzad O.C., Langer R. Nanotechnology in drug delivery and tissue engineering: from discovery to applications. Nano Lett 2010, 10:3223-3230.
7. Wang Y., Zhao Q., Hu Y., Sun L., Bai L., Jiang T., et al. Ordered nanoporous silica as carriers for improved delivery of water insoluble drugs: a comparative study between three dimensional and two dimensional macroporous silica. Int J Nanomedicine 2013, 8:4015-4031.
8. Kilpeläinen M., Riikonen J., Vlasova M., Huotari A., Lehto V., Salonen J., et al. In vivo delivery of a peptide, ghrelin antagonist, with mesoporous silicon microparticles. J Control Release 2009, 137:166-170.
9. Slowing I.I., Trewyn B.G., Giri S., Lin V.Y. Mesoporous silica nanoparticles for drug delivery and biosensing applications. Adv Funct Mater 2007, 17:1225-1236.
10. Giri S., Trewyn B.G., Lin V.S. Mesoporous silica nanomaterial-based biotechnological and biomedical delivery systems 2007, 2:99-111.
11. He Q., Zhang J., Shi J., Zhu Z., Zhang L., Bu W., et al. The effect of PEGylation of mesoporous silica nanoparticles on nonspecific binding of serum proteins and cellular responses. Biomaterials 2010, 31:1085-1092.
12. Kresge C., Leonowicz M., Roth W., Vartuli J., Beck J. Ordered mesoporous molecular sieves synthesized by a iquid-crystal template mechanism. Nature 1992, 359:710-712.
13. Cai Q., Lin W.-Y., Xiao F.-S., Pang W.-Q., Chen X.-H., Zou B.-S. The preparation of highly ordered MCM-41 with extremely low surfactant concentration. Microporous Mesoporous Mater 1999, 32:1-15.
14. Yang P., Gai S., Lin J. Functionalized mesoporous silica materials for controlled drug delivery. Chem Soc Rev 2012, 41:3679-3698.
15. Vallet-Regi M., Ramila A., Del Real R., Pérez-Pariente J. A new property of MCM-41: drug delivery system. Chem Mater 2001, 13:308-311.
16. Radu D.R. Mesoporous silica nanomaterials for applications in catalysis, sensing, drug delivery and gene transfection 2005, Ames Lab, Ames, IA (US).
17. Hu Y., Wang J., Zhi Z., Jiang T., Wang S. Facile synthesis of 3D cubic mesoporous silica microspheres with a controllable pore size and their application for improved delivery of a water-insoluble drug. J Colloid Interface Sci 2011, 363:410-417.
18. Hu Y., Zhi Z., Zhao Q., Wu C., Zhao P., Jiang H., et al. 3D cubic mesoporous silica microsphere as a carrier for poorly soluble drug carvedilol. Microporous Mesoporous Mater 2012, 147:94-101.
19. Sun L., Wang Y., Jiang T., Zheng X., Zhang J., Sun J., et al. Novel chitosan-functionalized spherical nanosilica matrix as an oral sustained drug delivery system for poorly water-soluble drug carvedilol. ACS Appl Mater Interfaces 2012, 5:103-113.
20. Nadrah P., Porta F., Planinsek O., Kros A., Gaberscek M. Poly (propylene imine) dendrimer caps on mesoporous silica nanoparticles for redox-responsive release: smaller is better. Phys Chem Chem Phys 2013, 15:10740-10748.
21. Hudson S.P., Padera R.F., Langer R., Kohane D.S. The biocompatibility of mesoporous silicates. Biomaterials 2008, 29:4045-4055.
22. Zhang Y., Wang J., Bai X., Jiang T., Zhang Q., Wang S. Mesoporous silica nanoparticles for increasing the oral bioavailability and permeation of poorly water soluble drugs. Mol Pharm 2012, 9:505-513.
23. Colilla M., Manzano M., Izquierdo-Barba I., Vallet-Regí Ma, Boissiére C., Sanchez C. Advanced drug delivery vectors with tailored surface properties made of mesoporous binary oxides submicronic spheres. Chem Mater 2009, 22:1821-1830.
24. He Q., Shi J., Zhu M., Chen Y., Chen F. The three-stage in vitro degradation behavior of mesoporous silica in simulated body fluid. Microporous Mesoporous Mater 2010, 131:314-320.
25. García A., Colilla M., Izquierdo-Barba I., Vallet-Regí Ma Incorporation of phosphorus into mesostructured silicas: a novel approach to reduce the SiO2 leaching in water. Chem Mater 2009, 21:4135-4145.
26. Souris J.S., Lee C.-H., Cheng S.-H., Chen C.-T., Yang C.-S., Ho J-aA, et al. Surface charge-mediated rapid hepatobiliary excretion of mesoporous silica nanoparticles. Biomaterials 2010, 31:5564-5574.
27. Lu J., Liong M., Li Z., Zink J.I., Tamanoi F. Biocompatibility, biodistribution, and drug-delivery efficiency of mesoporous silica nanoparticles for cancer therapy in animals. Small 2010, 6:1794-1805.
28. Wu H., Zhang S., Zhang J., Liu G., Shi J., Zhang L., et al. A hollow-core, magnetic, and mesoporous double-shell nanostructure: in situ decomposition/reduction synthesis, bioimaging, and drug-delivery properties. Adv Funct Mater 2011, 21:1850-1862.
29. Kim J., Kim H.S., Lee N., Kim T., Kim H., Yu T., et al. Multifunctional uniform nanoparticles composed of a magnetite nanocrystal core and a mesoporous silica shell for magnetic resonance and fluorescence imaging and for drug delivery. Angew Chem Int Ed 2008, 47:8438-8441.
30. Vallet-Regi M., Pérez-Pariente J., Izquierdo-Barba I., Salinas A. Compositional variations in the calcium phosphate layer growth on gel glasses soaked in a simulated body fluid. Chem Mater 2000, 12:3770-3775.
31. Hu Y., Zhi Z., Wang T., Jiang T., Wang S. Incorporation of indomethacin nanoparticles into 3-D ordered macroporous silica for enhanced dissolution and reduced gastric irritancy. Eur J Pharm Biopharm 2011, 79:544-551.
32. Ahern R.J., Hanrahan J.P., Tobin J.M., Ryan K.B., Crean A.M. Comparison of fenofibrate-mesoporous silica drug-loading processes for enhanced drug delivery. Eur J Pharm Sci 2013, 50:400-409.
33. Zhang Y., Jiang T., Zhang Q., Wang S. Inclusion of telmisartan in mesocellular foam nanoparticles: drug loading and release property. Eur J Pharm Biopharm 2010, 76:17-23.
34. Wang Y., Sun L., Jiang T., Zhang J., Zhang C., Sun C., et al. The investigation of MCM-48-type and MCM-41-type mesoporous silica as oral solid dispersion carriers for water insoluble cilostazol. Drug Dev Ind Pharm 2014, 40:819-828.
35. Mellaerts R., Mols R., Jammaer J.A., Aerts C.A., Annaert P., Van Humbeeck J., et al. Increasing the oral bioavailability of the poorly water soluble drug itraconazole with ordered mesoporous silica. Eur J Pharm Biopharm 2008, 69:223-230.
36. Zhang Y., Zhi Z., Jiang T., Zhang J., Wang Z., Wang S. Spherical mesoporous silica nanoparticles for loading and release of the poorly water-soluble drug telmisartan. J Control Release 2010, 145:257-263.
37. Jia L., Shen J., Li Z., Zhang D., Zhang Q., Duan C., et al. Successfully tailoring the pore size of mesoporous silica nanoparticles: exploitation of delivery systems for poorly water-soluble drugs. Int J Pharm 2012, 439:81-91.
38. Bossaert W.D., De Vos D.E., Van Rhijn W.M., Bullen J., Grobet P.J., Jacobs P.A. Mesoporous sulfonic acids as selective heterogeneous catalysts for the synthesis of monoglycerides. J Catal 1999, 182:156-164.
39. Qu F., Zhu G., Lin H., Zhang W., Sun J., Li S., et al. A controlled release of ibuprofen by systematically tailoring the morphology of mesoporous silica materials. J Solid State Chem 2006, 179:2027-2035.
40. Carriazo D., Del Arco M., Fernández A., Martín C., Rives V. Inclusion and release of fenbufen in mesoporous silica. J Pharm Sci 2010, 99:3372-3380.
41. Chen Y., Chen H., Ma M., Chen F., Guo L., Zhang L., et al. Double mesoporous silica shelled spherical/ellipsoidal nanostructures: synthesis and hydrophilic/hydrophobic anticancer drug delivery. J Mater Chem 2011, 21:5290-5298.
42. Vallet-Regí M. Ordered mesoporous materials in the context of drug delivery systems and bone tissue engineering. Chem A Eur J 2006, 12:5934-5943.
43. He Q., Zhang J., Chen F., Guo L., Zhu Z., Shi J. An anti-ROS/hepatic fibrosis drug delivery system based on salvianolic acid B loaded mesoporous silica nanoparticles. Biomaterials 2010, 31:7785-7796.
44. Gao W., Chan J.M., Farokhzad O.C. pH-responsive nanoparticles for drug delivery. Mol Pharm 2010, 7:1913-1920.
45. Meng H., Xue M., Xia T., Zhao Y.-L., Tamanoi F., Stoddart J.F., et al. Autonomous in vitro anticancer drug release from mesoporous silica nanoparticles by pH-sensitive nanovalves. J Am Chem Soc 2010, 132:12690-12697.
46. Saito G., Swanson J.A., Lee K.-D. Drug delivery strategy utilizing conjugation via reversible disulfide linkages: role and site of cellular reducing activities. Adv Drug Deliv Rev 2003, 55:199-215.
47. Lai C.-Y., Trewyn B.G., Jeftinija D.M., Jeftinija K., Xu S., Jeftinija S., et al. A mesoporous silica nanosphere-based carrier system with chemically removable CdS nanoparticle caps for stimuli-responsive controlled release of neurotransmitters and drug molecules. J Am Chem Soc 2003, 125:4451-4459.
48. Liu R., Zhao X., Wu T., Feng P. Tunable redox-responsive hybrid nanogated ensembles. J Am Chem Soc 2008, 130:14418-14419.
49. Weissman J.M., Sunkara H.B., Albert S.T., Asher S.A. Thermally switchable periodicities and diffraction from mesoscopically ordered materials. Science 1996, 274:959-963.
50. Zhou Z., Zhu S., Zhang D. Grafting of thermo-responsive polymer inside mesoporous silica with large pore size using ATRP and investigation of its use in drug release. J Mater Chem 2007, 17:2428-2433.
51. He D., He X., Wang K., Cao J., Zhao Y. A light-responsive reversible molecule-gated system using thymine-modified mesoporous silica nanoparticles. Langmuir 2012, 28:4003-4008.
52. Bernardos A., Mondragon L., Aznar E., Marcos M.D., Martínez-Máñez Rn, Sancenón Fl, et al. Enzyme-responsive intracellular controlled release using nanometric silica mesoporous supports capped with "saccharides". ACS Nano 2010, 4:6353-6368.
53. Meng H., Xue M., Xia T., Ji Z., Tarn D.Y., Zink J.I., et al. Use of size and a copolymer design feature to improve the biodistribution and the enhanced permeability and retention effect of doxorubicin-loaded mesoporous silica nanoparticles in a murine xenograft tumor model. ACS Nano 2011, 5:4131-4144.
54. Tang L., Gabrielson N.P., Uckun F.M., Fan T.M., Cheng J. Size-dependent tumor penetration and in vivo efficacy of monodisperse drug-silica nanoconjugates. Mol Pharm 2013, 10:883-892.
55. Rosenholm J.M., Meinander A., Peuhu E., Niemi R., Eriksson J.E., Sahlgren C., et al. Targeting of porous hybrid silica nanoparticles to cancer cells. ACS Nano 2008, 3:197-206.
56. Kralj S., Rojnik M., Kos J., Makovec D. Targeting EGFR-overexpressed A431 cells with EGF-labeled silica-coated magnetic nanoparticles. J Nanoparticle Res 2013, 15:1-11.
57. Pan L., He Q., Liu J., Chen Y., Ma M., Zhang L., et al. Nuclear-targeted drug delivery of TAT peptide-conjugated monodisperse mesoporous silica nanoparticles. J Am Chem Soc 2012, 134:5722-5725.
58. Deng Z., Zhen Z., Hu X., Wu S., Xu Z., Chu P.K. Hollow chitosan-silica nanospheres as pH-sensitive targeted delivery carriers in breast cancer therapy. Biomaterials 2011, 32:4976-4986.
59. Zhu Y., Ikoma T., Hanagata N., Kaskel S. Rattle-type Fe3O4@ SiO2 hollow mesoporous spheres as carriers for drug delivery. Small 2010, 6:471-478.
60. Huang S., Yang P., Cheng Z., Li C., Fan Y., Kong D., et al. Synthesis and characterization of magnetic Fe x O y@ SBA-15 composites with different morphologies for controlled drug release and targeting. J Phys Chem C 2008, 112:7130-7137.
61. Ashley C.E., Carnes E.C., Phillips G.K., Padilla D., Durfee P.N., Brown P.A., et al. The targeted delivery of multicomponent cargos to cancer cells by nanoporous particle-supported lipid bilayers. Nat Mater 2011, 10:389-397.
62. Huang X., Li L., Liu T., Hao N., Liu H., Chen D., et al. The shape effect of mesoporous silica nanoparticles on biodistribution, clearance, and biocompatibility in vivo. ACS Nano 2011, 5:5390-5399.
63. Cho M., Cho W.-S., Choi M., Kim S.J., Han B.S., Kim S.H., et al. The impact of size on tissue distribution and elimination by single intravenous injection of silica nanoparticles. Toxicol Lett 2009, 189:177-183.
64. Chen Z., Li Z., Lin Y., Yin M., Ren J., Qu X. Biomineralization inspired surface engineering of nanocarriers for pH-responsive, targeted drug delivery. Biomaterials 2013, 34:1364-1371.
65. Luo Z., Cai K., Hu Y., Zhao L., Liu P., Duan L., et al. Mesoporous silica nanoparticles end-capped with collagen: redox-responsive nanoreservoirs for targeted drug delivery. Angew Chem Int Ed 2011, 50:640-643.
66. Porta F., Lamers G.E., Morrhayim J., Chatzopoulou A., Schaaf M., den Dulk H., et al. Folic acid-modified mesoporous silica nanoparticles for cellular and nuclear targeted drug delivery. Adv Healthc Mater 2013, 2:281-286.
67. Giri S., Trewyn B.G., Stellmaker M.P., Lin V.S.Y. Stimuli-responsive controlled-release delivery system based on mesoporous silica nanorods capped with magnetic nanoparticles. Angew Chem Int Ed 2005, 44:5038-5044.
68. 4 nanoparticles-capped mesoporous silica. Biomaterials 2011, 32:1932-1942.
69. Chen Z., Li Z., Lin Y., Yin M., Ren J., Qu X. Bioresponsive hyaluronic acid-capped mesoporous silica nanoparticles for targeted drug delivery. Chem A Eur J 2013, 19:1778-1783.
70. Guo R., Li L.-L., Zhao W.-H., Chen Y.-X., Wang X.-Z., Fang C.-J., et al. The intracellular controlled release from bioresponsive mesoporous silica with folate as both targeting and capping agent. Nanoscale 2012, 4:3577-3583.
71. Zhang J., Yuan Z.-F., Wang Y., Chen W.-H., Luo G.-F., Cheng S.-X., et al. Multifunctional envelope-type mesoporous silica nanoparticles for tumor-triggered targeting drug delivery. J Am Chem Soc 2013, 135:5068-5073.
72. Hudson S., Cooney J., Magner E. Proteins in mesoporous silicates. Angew Chem Int Ed 2008, 47:8582-8594.
73. Nguyen T.P.B., Lee J.-W., Shim W.G., Moon H. Synthesis of functionalized SBA-15 with ordered large pore size and its adsorption properties of BSA. Microporous Mesoporous Mater 2008, 110:560-569.
74. Betancor L., Luckarift H.R. Bioinspired enzyme encapsulation for biocatalysis. Trends Biotechnol 2008, 26:566-572.
75. Slowing I.I., Trewyn B.G., Lin V.S.-Y. Mesoporous silica nanoparticles for intracellular delivery of membrane-impermeable proteins. J Am Chem Soc 2007, 129:8845-8849.
76. Wang Y., Caruso F. Mesoporous silica spheres as supports for enzyme immobilization and encapsulation. Chem Mater 2005, 17:953-961.
77. Carvalho L.V., Ruiz RdC, Scaramuzzi K., Marengo E.B., Matos J.R., Tambourgi D.V., et al. Immunological parameters related to the adjuvant effect of the ordered mesoporous silica SBA-15. Vaccine 2010, 28:7829-7836.
78. Torney F., Trewyn B.G., Lin V.S.-Y., Wang K. Mesoporous silica nanoparticles deliver DNA and chemicals into plants. Nat Nanotechnol 2007, 2:295-300.
79. Radu D.R., Lai C.-Y., Jeftinija K., Rowe E.W., Jeftinija S., Lin V.S.-Y. A polyamidoamine dendrimer-capped mesoporous silica nanosphere-based gene transfection reagent. J Am Chem Soc 2004, 126:13216-13217.
80. Li X., Xie Q.R., Zhang J., Xia W., Gu H. The packaging of siRNA within the mesoporous structure of silica nanoparticles. Biomaterials 2011, 32:9546-9556.
81. Koenderink G.H., Sacanna S., Pathmamanoharan C., Rasa M., Philipse A.P. Preparation and properties of optically transparent aqueous dispersions of monodisperse fluorinated colloids. Langmuir 2001, 17:6086-6093.
82. Pan J., Wan D., Gong J. PEGylated liposome coated QDs/mesoporous silica core-shell nanoparticles for molecular imaging. Chem Commun 2011, 47:3442-3444.
83. Tsou C.-J., Chu C.-Y., Hung Y., Mou C.-Y. A broad range fluorescent pH sensor based on hollow mesoporous silica nanoparticles, utilising the surface curvature effect. J Mater Chem B 2013, 1:5557-5563.
84. Zhang F., Braun G.B., Pallaoro A., Zhang Y., Shi Y., Cui D., et al. Mesoporous multifunctional upconversion luminescent and magnetic "nanorattle" materials for targeted chemotherapy. Nano Lett 2011, 12:61-67.
85. Hricak H. MR imaging and MR spectroscopic imaging in the pre-treatment evaluation of prostate cancer 2014.
86. Wartenberg N., Fries P., Raccurt O., Guillermo A., Imbert D., Mazzanti M. A gadolinium complex confined in silica nanoparticles as a highly efficient T1/T2 MRI contrast agent. Chem A Eur J 2013, 19:6980-6983.
87. Rieter W.J., Kim J.S., Taylor K.M., An H., Lin W., Tarrant T., et al. Hybrid silica nanoparticles for multimodal imaging. Angew Chem Int Ed 2007, 46:3680-3682.
88. Kim J.S., Rieter W.J., Taylor K.M., An H., Lin W., Lin W. Self-assembled hybrid nanoparticles for cancer-specific multimodal imaging. J Am Chem Soc 2007, 129:8962-8963.
89. Piao Y., Burns A., Kim J., Wiesner U., Hyeon T. Designed fabrication of silica-based nanostructured particle systems for nanomedicine applications. Adv Funct Mater 2008, 18:3745-3758.
90. Burns A., Ow H., Wiesner U. Fluorescent core-shell silica nanoparticles: towards "lab on a particle" architectures for nanobiotechnology. Chem Soc Rev 2006, 35:1028-1042.
91. Trewyn B.G., Slowing I.I., Giri S., Chen H.-T., Lin V.S.-Y. Synthesis and functionalization of a mesoporous silica nanoparticle based on the sol-gel process and applications in controlled release. Acc Chem Res 2007, 40:846-853.
92. Taylor K.M., Kim J.S., Rieter W.J., An H., Lin W., Lin W. Mesoporous silica nanospheres as highly efficient MRI contrast agents. J Am Chem Soc 2008, 130:2154-2155.
93. Cormode D.P., Skajaa T., van Schooneveld M.M., Koole R., Jarzyna P., Lobatto M.E., et al. Nanocrystal core high-density lipoproteins: a multimodality contrast agent platform. Nano Lett 2008, 8:3715-3723.
94. Seo W.S., Lee J.H., Sun X., Suzuki Y., Mann D., Liu Z., et al. FeCo/graphitic-shell nanocrystals as advanced magnetic-resonance-imaging and near-infrared agents. Nat Mater 2006, 5:971-976.
95. Chen Y., Yin Q., Ji X., Zhang S., Chen H., Zheng Y., et al. Manganese oxide-based multifunctionalized mesoporous silica nanoparticles for pH-responsive MRI, ultrasonography and circumvention of MDR in cancer cells. Biomaterials 2012, 33:7126-7137.
96. Castner D.G., Ratner B.D. Biomedical surface science: Foundations to frontiers. Surf Sci 2002, 500:28-60.
97. Beck G.R., Ha S.-W., Camalier C.E., Yamaguchi M., Li Y., Lee J.-K., et al. Bioactive silica-based nanoparticles stimulate bone-forming osteoblasts, suppress bone-resorbing osteoclasts, and enhance bone mineral density in vivo. Nanomedicine 2012, 8:793-803.
98. Izquierdo-Barba I., Ruiz-González L., Doadrio J.C., González-Calbet J.M., Vallet-Regí M. Tissue regeneration: a new property of mesoporous materials. Solid State Sci 2005, 7:983-989.
99. Vallet-Regí M., Izquierdo-Barba I., Rámila A., Pérez-Pariente J., Babonneau F., González-Calbet J.M. Phosphorous-doped MCM-41 as bioactive material. Solid State Sci 2005, 7:233-237.
100. Horcajada P., Rámila A., Boulahya K., González-Calbet J., Vallet-Regí M. Bioactivity in ordered mesoporous materials. Solid State Sci 2004, 6:1295-1300.
101. Balas F., Manzano M., Colilla M., Vallet-Regí M. L-Trp adsorption into silica mesoporous materials to promote bone formation. Acta Biomater 2008, 4:514-522.
102. Vallet-Regí M., Ruiz-González L., Izquierdo-Barba I., González-Calbet J.M. Revisiting silica based ordered mesoporous materials: medical applications. J Mater Chem 2006, 16:26-31.
103. Fu C., Liu T., Li L., Liu H., Chen D., Tang F. The absorption, distribution, excretion and toxicity of mesoporous silica nanoparticles in mice following different exposure routes. Biomaterials 2013, 34:2565-2575.